bortezomib cipla 3,5 mg polvo para solucion inyectable efg
cipla europe nv - bortezomib - polvo para soluciÓn inyectable - 3,5 mg - bortezomib 3,5 mg - bortezomib
bortezomib krka 3,5 mg polvo para solucion inyectable efg
krka d.d. novo mesto - bortezomib - polvo para soluciÓn inyectable - 3,5 mg - bortezomib 3,5 mg - bortezomib
bortezomib ever pharma 2,5 mg/ml solucion inyectable
ever valinject gmbh - bortezomib - soluciÓn inyectable - 3,5 mg inyectable 1,4 ml - bortezomib 2,5 mg - bortezomib
bortezomib baxter 3,5 mg polvo para solucion inyectable efg
baxter holding b.v. - bortezomib - polvo para soluciÓn inyectable - 3,5 mg - bortezomib 3,5 mg - bortezomib
phelinun
adienne s.r.l. s.u. - melphalan hydrochloride - multiple myeloma; hodgkin disease; lymphoma, non-hodgkin; precursor cell lymphoblastic leukemia-lymphoma; leukemia, myeloid, acute; neuroblastoma; ovarian neoplasms; hematopoietic stem cell transplantation - agentes antineoplásicos - high-dose of phelinun used alone or in combination with other cytotoxic medicinal products and/or total body irradiation is indicated in the treatment of:multiple myeloma,malignant lymphoma (hodgkin, non-hodgkin lymphoma),acute lymphoblastic and myeloblastic leukemia,childhood neuroblastoma,ovarian cancer,mammary adenocarcinoma. phelinun in combination with other cytotoxic medicinal products is indicated as reduced intensity conditioning (ric) treatment prior to allogeneic haematopoietic stem cell transplantation (allo-hsct) in malignant haematological diseases in adults. phelinun in combination with other cytotoxic medicinal products is indicated as conditioning regimen prior to allogeneic haematopoietic stem cell transplantation in haematological diseases in the paediatric population as:myeloablative conditioning (mac) treatment in case of malignant haematological diseasesric treatment in case of non-malignant haematological diseases.
dexametasona tad 40 mg comprimidos
tad pharma gmbh - dexametasona - comprimido - 40 mg - dexametasona 40 mg - dexametasona
dexametasona tad 8 mg comprimidos
tad pharma gmbh - dexametasona - comprimido - 8 mg - dexametasona 8 mg - dexametasona
dexametasona tad 20 mg comprimidos
tad pharma gmbh - dexametasona - comprimido - 20 mg - dexametasona 20 mg - dexametasona
dexametasona tad 4 mg comprimidos
tad pharma gmbh - dexametasona - comprimido - 4 mg - dexametasona 4 mg - dexametasona
melfalan zentiva 50 mg polvo y disolvente para solucion inyectable y para perfusion efg
zentiva k.s. - melfalan hidrocloruro - polvo y disolvente para soluciÓn inyectable y para perfusiÓn - 50 mg - melfalan hidrocloruro 50 mg - melfalán